Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
Overall survival higher in group receiving pembrolizumab plus chemo versus chemotherapy alone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.